Cc1ccc(C(=O)N/N=C(\N=N\c2ccc([N+](=O)[O-])cc2)c2ccc(N(CCC#N)CCC#N)cc2C)cc1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?